SynCore Biotechnology Co Ltd (4192) — Long-term Investment Intensity
SynCore Biotechnology Co Ltd (4192) has a Long-term Investment Intensity of 4.0% as of December 2019. Long-term investments of NT$30.39 Million represent 4.0% of total assets of NT$763.88 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SynCore Biotechnology Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SynCore Biotechnology Co Ltd Long-term Investment Intensity (2015–2019)
This chart shows how SynCore Biotechnology Co Ltd's Long-term Investment Intensity has evolved across 5 annual periods from 2015 to 2019. As of December 2019, the intensity stands at 4.0%, reflecting long-term investments of NT$30.39 Million against total assets of NT$763.88 Million TWD. Explore 4192 operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for SynCore Biotechnology Co Ltd (2015–2019)
The table below presents the year-by-year Long-term Investment Intensity for SynCore Biotechnology Co Ltd from 2015 to 2019, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see SynCore Biotechnology Co Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (TWD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 4.0% | NT$30.39 Million | NT$763.88 Million | ▼ -3.3 pp |
| 2018 | 7.3% | NT$58.87 Million | NT$804.80 Million | ▼ -4.8 pp |
| 2017 | 12.1% | NT$102.65 Million | NT$845.89 Million | ▲ +4.0 pp |
| 2016 | 8.1% | NT$90.44 Million | NT$1.11 Billion | ▼ -15.1 pp |
| 2015 | 23.2% | NT$238.34 Million | NT$1.03 Billion | — |